Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.
Condition: Hepatocellular Carcinoma Intervention: Drug: Sorafenib Tablets Sponsors: Damanhour University; Mransoura University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Egypt Health | Hepatocellular Carcinoma | Liver Cancer | Research